Investor
OrbiMed
PE firm
Key details
- Profile type
- Organization
- Geography
- New York City, New York, USA
- Stage
- 3. Early Revenue, 4. Scaling, 5. Growth, 6. Pre-IPO
- Sector
- life sciences, biomarker, medical devices, psychedelic, CBD, medical device, mental health, digital-health, well-being, medicines, metabolites, lifesciences, wellbeing, therapy, healthtech, cannabis, connected health, biopharma, telehealth, in vitro diagnostics, biomarkers, diagnostics, e-health, med device, bio, health, biotech, pharma, drugs, bioimaging, protein, pharmaceuticals, therapeutic, tech-enabled health, wellness, mRNA, CGT, drug, cell therapy, gene therapy, metabolomics, transcriptomics, therapeutics, health-tech, lifescience, longevity, life science, healthcare, genomics, life sciences tools, psychedelics, ehealth, life-science, medtech, IVD, healthier living, proteomics, connected-health
- Invests in
- ["Austria","Canada","China","Denmark","France","Germany","Hong Kong","India","Ireland","Israel","South Korea","Spain","Sweden","Switzerland","Netherlands","UK","USA"]
- Investment size
- $1M to $75M
- Founder groups
- Not publicly stated
Official source
TorontoStarts does not endorse or rank this record. Confirm current details with the official source.